Sepinostat Mesilate

Drugs of the Future

Volumn 22, Issue 5, 1997, Pages 502-507

  Graul, A ^a   Leeson, P ^a   Castaner J ^a  

^a PROUS SCIENCE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

SEPINOSTAT; SERINE PROTEINASE INHIBITOR; UNCLASSIFIED DRUG;

CLINICAL ARTICLE; CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG STABILITY; DRUG SYNTHESIS; GASTROINTESTINAL SYMPTOM; HUMAN; HUMAN CELL; HUMAN TISSUE; MUTAGENICITY; ORAL DRUG ADMINISTRATION; PANCREATITIS; PHASE 2 CLINICAL TRIAL; PROTEINASE INHIBITION; REFLUX ESOPHAGITIS; REPRODUCTIVE TOXICITY; REVIEW;

EID: 0030742426     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.1997.022.05.408602     Document Type: Review

References (35)

1. Nakayama, T., Taira, S., Ikeda, M., Ashizawa, H., Oda, M., Arakawa, K., Fujii, S. Synthesis and structure-activity study of protease inhibitors. V. Chemical modification of 6-amidino-2-naphthyl 4-guanidinobenzoate. Chem Pharm Bull 1993, 41: 117-25.
2. Fujii, S., Okutome, T., Nakayama, T., Nunomura, S., Sudo, K., Watanabe, S., Kurumi, M., Aoyama, T. (Torii & Co., Ltd.). Novel amidine cpds. AU 8545492, EP 190356, ES 8607218, US 4777182, US 4820730, WO 8600893.
3. Oda, M., Ino, Y., Nakamura, K., Kuramoto, S., Shimamura, K., Iwaki, M., Fujii, S. Pharmacological studies on 6-amidino-2-naphthyl[4-(4,5-dihydro-1H-imidazol-2-yl)amino]benzoate dimethane sulfonate (FUT-187). I: Inhibitory activities on various kinds of enzymes in vitro and anticomplement activity in vivo. Jpn J Pharmacol 1990, 52: 23-34.
4. Nakamura, K., Johmura, A., Oda, M., Ino, Y., Uchiyama, H., Ohtani, H., Miyazaki, H., Kurumi, M., Akizawa, Y., Oka, T. Inhibitory effects of sepimostat mesilate (FUT-187) on the activities of trypsin-like serine proteases in vitro. Yakugaku Zasshi 1995, 115: 201-12.
5. Murakami, H., Togawa, M., Takahashi, S., Kasahara, N., Yamamoto, J., Matsuura, N., Koshiyama, Y., Ino, Y., Oda, M. Pharmacological studies of 6-amidino-2-naphthyl 4-[(4,5-dihydro-1H-imidazol-2-yl)amino]benzoate dimethanesulfonate. Effects on experimental pancreatitis. Arzneim-Forsch-Drug Res 1990, 40: 1352-8.
6. Wang, Z.H., Manabe, T., Ohshio, G., Hirano, T., Okada, N., Imamura, T., Kawaguchi, Y., Yotsumoto, F., Yamaki, K., Imamura, M. Effects of the oral administration of sepimostat mesilate on cerulein induced acute pancreatitis in rats. Arzneim-Forsch-Drug Res 1995, 45: 1082-6.
7. Hirano, T. Synthetic protease inhibitor prevents impaired hepatic secretion of lysosomal enzymes into bile and hepatic lysosomal fragility induced by endotoxin in rats. Dig Surg 1996, 13: 478-83.
8. Hirano, T. Pancreatic injuries in rats with fecal peritonitis: Protective effect of a new synthetic protease inhibitor, sepinostat mesilate (FUT-187). J Surg Res 1996, 61: 301-6.
9. Oda, M., Kojima, T., Koshiyama, Y. et al. General pharmacology of 6-amidino-2-naphthyl 4-[(4,5-dihydro-1H-imidazol-2-yl)amino]benzoate dimethanesulfonate (FUT-187) (1). Effects on central and peripheral nervous systems. Pharmacometrics 1991, 41: 1-11.
10. Kojima, T., Ino, Y., Koshiyama, Y. et al. General pharmacology of 6-amidino-2-naphthyl 4-[(4,5-dihydro-1H-imidazol-2-yl)amino]benzoate dimethanesulfonate (FUT-187) (2). Effects on respiratory and cardiovascular systems, isolated smooth muscles and others. Pharmacokinetics 1991, 41: 13-24.
11. Kawasaki, K., Terasoma, M., Seki, H., Yokomoto, Y., Ohuchida, A. Reverse mutation test of 6-amidino-2-naphthyl 4-[(4,5-dihydro-1H-imidazol-2-yl)amino]benzoate dimethanesulfonate (FUT-187) with bacteria. Clin Rep 1994, 28(3): 9-17.
12. Matsumura, H., Matsumoto, K., Ohta, T., Yokomoto, Y., Ohuchida, A. Chromosomal aberration test of 6-amidino-2-naphthyl 4-[(4,5-dihydro-1H-imidazol-2-yl)amino]benzoate dimethanesulfonate (FUT-187) in CHL cells. Clin Rep 1994, 28(3): 19-24.
13. Suzuki, O., Terasoma, M., Seki, H., Yokomoto, Y., Ohuchida, A. Micronucleus test of 6-amidino-2-naphthyl 4-[(4,5-dihydro-1H-imidazol-2-yl)amino]benzoate dimethanesulfonate (FUT-187) in mice. Clin Rep 1994, 28(3): 25-8.
14. Shimamura, K., Terabayashi, M., Kuramoto, S., Hasegawa, N., Terazawa, K., Maruden, A. Reproductive and developmental toxicity studies of 6-amidino-2-naphthyl 4(-)[(4,5-dihydro-1H-imidazol-2-yl)amino]benzoate dimethanesulfonate (FUT-187). (IV) - Oral administration to New Zealand white rabbits during the period of fetal organogenesis. [Published erratum appears in J Toxicol Sci 1995, 20(1): 76]. J Toxicol Sci 1992, 17(Suppl. 4): 253-61.
15. Shimamura, K., Terazawa, K., Terabayashi, M., Watanabe, K., Hasegawa, N., Kuramoto, S., Yokomoto, Y., Otani, K., Maruden, A. Reproductive and developmental toxicity study of 6-amidino-2-naphthyl 4-(-)[(4,5-dihydro-1H-imidazol-2-yl)amino]benzoate dimethanesulfonate (FUT-187). (II) - Oral administration to rats during the period of fetal organogenesis (prenatal examination). [Published erratum appears in J Toxicol Sci 1995, 20(1): 76]. J Toxicol Sci 1992, 17(Suppl. 4): 221-30.
16. Kawanishi, H., Shiraishi, M., Igarashi, Y., Takeshima, T., Toyohara, S., Imai, S., Shimamura, K., Maruden, A. Reproductive and developmental toxicity studies of FUT-187. (III) - Postnatal study in rat F1 offspring from dams treated orally with FUT-187 during the period of fetal organogenesis. J Toxicol Sci 1992, 17(Suppl. 4): 231-52.
17. Furuhashi, T., Uehara, M., Takei, A., Kurihara, H., Yoshida, R., Maruden, A., Shimamura, K. Reproductive and developmental toxicity studies of FUT-187. (V) - Perinatal and postnatal study in rats with oral administration of FUT-187. J Toxicol Sci 1992, 17(Suppl. 4): 263-86.
18. Furuhashi, T., Uehara, M., Kodama, R., Yoshida, R., Maruden, A., Shimamura, K. Reproductive and developmental toxicity studies of FUT-187. (I) - Fertility study in rats with oral administration of FUT-187. J Toxicol Sci 1992, 17(Suppl. 4): 201-19.
19. Watanabe, K., Terazawa, K., Terabayashi, M., Kuramoto, S., Yokomoto, Y., Otani, K., Sato, K., Kurotori, M., Shimamura, K., Yamashita, K. A 13-week subacute oral toxicity study of 6-amidino-2-naphthyl 4-[(4,5-dihydro-1H-imidazol-2-yl)amino]benzoate dimethanesulfonate (FUT-187) in dogs. [Published errata appear in J Toxicol Sci 1993, 18(4): 276-7 and 1995, 20(1): 74-5]. J Toxicol Sci 1992, 17(Suppl. 4): 61-99.
20. Okazaki, S., Todate, A., Yamazaki, E., Anabuki, K., Tamura, K., Hoshiya, T., Maruden, A., Terazawa, K. A 13-week subacute oral toxicity study of 6-amidino-2-naphthyl 4-[(4,5-dihydro-1H-imidazol-2-yl)amino]benzoate dimethanesulfonate (FUT-187) in rats. J Toxicol Sci 1992, 17(Suppl. 4): 17-59.
21. Spicer, E.J., Maruden, A., Terazawa, K. The evaluation of 6-amidino-2-naphthyl 4-[(4,5-dihydro-1H-imidazol-2-yl)amino]benzoate dimethanesulfonate (FUT-187) by oral administration in cynomolgus monkeys in a 13 week subacute toxicity study. J Toxicol Sci 1992, 17(Suppl. 4): 101-23.
22. Nakano, S., Yada, H., Irimura, K., Asanoma, H., Hirota, T., Terazawa, K. A 52-week chronic oral toxicity study of 6-amidino-2-naphthyl 4-[(4,5-dihydro-1H-imidazol-2-yl)amino]benzoate dimethanesulfonate (FUT-187) in dogs. J Toxicol Sci 1992, 17(Suppl. 4): 163-99.
23. Okazaki, S., Yamazaki, E., Hatayama, K., Tamura, K., Aikawa, T., Terazawa, K., Maruden, A. A 52-week oral chronic toxicity study of 6-amidino-2-naphthyl 4-[(4,5-dihydro-1H-imidazol-2-yl)amino]benzoate dimethanesulfonate (FUT-187) in rats with a recovery period of 5 weeks. [Published erratum appears in J Toxicol Sci 1995, 20(1): 75]. J Toxicol Sci 1992, 17(Suppl. 4): 125-62.
24. Kurotori, M., Suzuki, M., Arakawa, K. et al. Pharmacokinetic studies of sepimostat mesilate (FUT-187) [VI] - Absorption and linearity of sepimostat mesilate and its metabolites after single administration in rats and dogs. Clin Rep 1996, 30(10): 9-24.
25. Kurotori, M., Suzuki, M., Arakawa, K. et al. Pharmacokinetic studies of sepimostat mesilate (FUT-187) [VII] - First pass effect of sepimostat mesilate in rats. Clin Rep 1996, 30(10): 25-36.
26. Kurotori, M., Suzuki, M., Arakawa, K. et al. Pharmacokinetic studies of sepimostat mesilate (FUT-187) [VIII] - Tissue distribution after single administration in rats and dogs. Clin Rep 1996, 30(10): 37-52.
27. Kurotori, M., Suzuki, M., Arakawa, K. et al. Pharmacokinetic studies of sepimostat mesilate (FUT-187) [IX] - Metabolic disposition of sepimostat mesilate and its metabolites after repeated oral administration in rats. Clin Rep 1996, 30(10): 53-68.
28. Tei, M., Kodama, K., Yafune, A. et al. Pharmacokinetic studies of sepimostat mesilate (FUT-187) after oral administration in healthy volunteers. Clin Rep 1996, 30(10): 239-56.
29. Kurotori, M., Suzuki, M., Arakawa, K., Sato, T., Tsuda, M., Karasawa, Y., Seki, H., Hayashi, K., Takenouchi, N. Pharmacokinetic studies of sepimostat mesilate (FUT-187) [X] - Plasma protein binding of sepimostat mesilate and its metabolites. Clin Rep 1996, 30(10): 69-75.
30. Sasaki, N., Midorikawa, A., Arakawa, K. Stability studies on 6-amidino-2-naphthyl 4-[(4,5-dihydro-1H-imidazol-2-yl)amino]benzoate dimethanesulfonate (FUT-187) in aqueous solution. Yakugaki Zasshi 1992, 112: 544-50.
31. Marunaka, T., Maniwa, M., Matsushima, E., Yoshida, K., Azuma, R. High-performance liquid chromatographic determination of 6-amidino-2-naphthyl [4-(4,5-dihydro-1H-imidazol-2-yl)amino]benzoate dimethanesulphonate and its metabolites in biological fluids. J Chromatogr Biomed Appl 1988, 433: 177-86.
32. Yoshino, K., Oomori, T. Clinical experience with a novel oral protease inhibitor (FUT-187) in postgastrectomy reflux esophagitis. Jpn Pharmacol Ther 1995, 23(1): 191-7.
33. Abe, O., Yoshino, K., Uchino, J. et al. Late phase II study of sepimostat mesilate (FUT-187) in postgastrectomy reflux esophagitis - Clinical optimum dose in a double blind study. Jpn Pharmacol Ther 1996, 24(4): 143-57.
34. Toge, T., Hirai, T., Takiyama, W. et al. Clinical effects of FUT-187 in reflux esophagitis after gastrectomy. Jpn J Cancer Chemother 1995, 22: 539-46.
35. Makuuchi, H., Kanno, K., Mitomi, T. Clinical usefulness of FUT-187 (sepimostat mesilate) on reflux esophagitis and gastritis after gastrectomy. Jpn J Cancer Chemother 1995, 22: 777-83.